[ad_1] At the American Society of Retina Specialists meeting, our team & colleagues had numerous presentations on #retina clinical science as well as #suprachoroidal delivery of tyrosine kinase inhibitor, complement Inhibitor & corticosteroid. #biotech #medicine #clinicalresearch [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @Ophthalmologymg: Update on gene therapy: Ocular gene therapy research has shown tremendous growth over recent years. This article discu… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Recently co-authored “Update on gene therapy: A discussion of strategies, optimization, alternatives and administration… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @VestrumHealth: https://t.co/On63W7xSpL [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ViralKansaraPhD: I had the privilege of being a part of the research where my colleagues and I examined the “biofactory approach” in #G… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Recently co-authored “Update on gene therapy: A discussion of strategies, optimization, alternatives and administration”, in Ophthalmology Management’s “Future of Retinal Care” issue… #genetherapy #ophthalmology #amd #diabetes #retina #eyes https://t.co/bXNWa4p7G0 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Just authored this @RetinalPhys​ article highlighting our #research on a leading cause of #vision loss. More effective and longer acting #treatments are needed! Retinal Physician – Anti-VEGF Therapy in Macular Edema Due to Retinal Vein Occlusion https://t.co/tR4b3mO078 [ad_2] Source by Thomas Ciulla, MD, MBA …